Table 3.

Statistical analysis of the overall mortality rate and conversion rate of mild or moderate disease to severe disease.

Baseline HM	Died, n (%)	Transferred to Critical Care, n (%)
Acute lymphocytic leukemia	0	0
Chronic lymphocytic leukemia	0	0
Acute myelogenous leukemia	1 (6.7)	3 (20)
Chronic myelogenous leukemia	0	0
Myelodysplastic syndrome	1 (11.1)	2 (22.2)
Lymphoma	1 (6.3)	4 (25)
Primary thrombocythemia	1 (100)	1 (100)
Primary myelofibrosis	0	0
Multiple myeloma	1 (8.3)	3 (25)
Age
≥ 60 years old	2 (3.1)	5 (7.8)
< 60 years old	3 (4.7)	8 (12.5)
Disease grade
Mild	1 (4.3)	2 (8.7)
Moderate	2 (7.7)	6 (23.1)
Severe	2 (13.3)	5 (33.3)
Treatment method
Nirmatrelvir-ritonavir group	2 (9.1)	7 (31.8)
Azvudine group	3 (17.6)	4 (23.5)
Observation group	0	2 (8)
Neo-crown vaccination
Not vaccinated	3 (11.5)	6 (23.1)
Already vaccinated	2 (5.3)	7 (18.4)